Company news

Share this article:
Bayer has filed a patent infringement lawsuit in US Federal Court in the Southern District of New York against Watson Pharmaceuticals, Watson Laboratories and Sandoz. Bayer's suit concerns Watson's and Sandoz's respective applications to the FDA for approval to market a generic form of Bayer Schering Pharma's oral contraceptive Yasmin.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters